Search Results - "Gralinski, M."

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Investigation of mechanism of drug‐induced cardiac injury and torsades de pointes in cynomolgus monkeys by Misner, DL, Frantz, C, Guo, L, Gralinski, MR, Senese, PB, Ly, J, Albassam, M, Kolaja, KL

    Published in British journal of pharmacology (01-04-2012)
    “…BACKGROUND AND PURPOSE Drug candidates must be thoroughly investigated for their potential cardiac side effects. During the course of routine toxicological…”
    Get full text
    Journal Article
  2. 2

    Cardioprotective effects of ranolazine (RS-43285) in the isolated perfused rabbit heart by Gralinski, M R, Black, S C, Kilgore, K S, Chou, A Y, McCormack, J G, Lucchesi, B R

    Published in Cardiovascular research (01-08-1994)
    “…The aim was to examine the putative cardioprotective effects of the novel antianginal agent, ranolazine, using an isolated rabbit heart model of ischaemia and…”
    Get more information
    Journal Article
  3. 3

    Localization of cyclooxygenase isozymes in cardiovascular tissues of dogs treated with naproxen by Stanfield, Kristina M., Khan, K.Nasir, Gralinski, Michael R.

    Published in Veterinary immunology and immunopathology (10-08-2001)
    “…Prostaglandins have diverse roles in the cardiovascular system mediating both physiologic and inflammatory responses. Two cyclooxygenase isoforms,…”
    Get full text
    Journal Article
  4. 4

    Effects of Heparin and N-Acetyl Heparin on Ischemia/Reperfusion-Induced Alterations in Myocardial Function in the Rabbit Isolated Heart by Friedrichs, Gregory S, Kilgore, Kenneth S, Manley, Peter J, Gralinski, Michael R, Lucchesi, Benedict R

    Published in Circulation research (01-10-1994)
    “…Evidence is presented that heparin pretreatment produces protective effects on myocardial tissue distinct from its anticoagulant activity. The present study…”
    Get full text
    Journal Article
  5. 5

    Cardioprotective effects of heparin or N-acetylheparin in an in vivo model of myocardial ischaemic and reperfusion injury by Black, S C, Gralinski, M R, Friedrichs, G S, Kilgore, K S, Driscoll, E M, Lucchesi, B R

    Published in Cardiovascular research (01-05-1995)
    “…The aim was to determine if either heparin or N-acetylheparin could reduce the extent of myocardial injury resulting from 90 min of coronary artery occlusion…”
    Get more information
    Journal Article
  6. 6

    Effects of Troglitazone and Pioglitazone on Cytokine-Mediated Endothelial Cell Proliferation In Vitro by Gralinski, Michael R, Rowse, Paul E, Breider, Michael A

    Published in Journal of cardiovascular pharmacology (01-06-1998)
    “…We examined whether troglitazone and pioglitazone, antidiabetic thiazolidinediones, would directly induce endothelial cell proliferation or influence…”
    Get full text
    Journal Article
  7. 7

    The assessment of potential for QT interval prolongation with new pharmaceuticals: Impact on drug development by Gralinski, Michael R

    “…Few examinations of a single physiological variable can end the development of a putative new pharmaceutical. Prolongation of the electrocardiographic QT…”
    Get full text
    Journal Article
  8. 8

    Effect of ranolazine on infarct size in a canine model of regional myocardial ischemia/reperfusion by Black, S C, Gralinski, M R, McCormack, J G, Driscoll, E M, Lucchesi, B R

    Published in Journal of cardiovascular pharmacology (01-12-1994)
    “…We assessed ranolazine's potential to reduce myocardial injury resulting from 90-min occlusion and 18-h reperfusion of left circumflex coronary artery (LCX) in…”
    Get more information
    Journal Article
  9. 9

    MS-551 protects against ventricular fibrillation in a chronic canine model of sudden cardiac death by Friedrichs, G S, Chi, L, Gralinski, M R, Black, S C, Basler, G C, Mu, D X, Pewitt, S R, Johnson, C R, Lucchesi, B R

    Published in Journal of cardiovascular pharmacology (01-02-1995)
    “…We studied the electrophysiologic and antifibrillatory properties of MS-551 (1,3-dimethyl-6-((2-[N-hydroxy-ethyl)-3-(4-nitrophenyl) propylamino] ethylamino)…”
    Get more information
    Journal Article
  10. 10

    Reviparin-Sodium Prevents Complement-Mediated Myocardial Injury in the Isolated Rabbit Heart by Park, James L, Tanhehco, Elaine J, Kilgore, Kenneth S, Gralinski, Michael R, Lucchesi, Benedict R

    Published in Journal of cardiovascular pharmacology (01-11-1997)
    “…The cytoprotective action of reviparin-sodium (LU-47311; Clivarin), a low-molecular-weight heparin, was examined in an ex vivo model of complement-mediated…”
    Get full text
    Journal Article
  11. 11

    Heat stress protects the perfused rabbit heart from complement-mediated injury by Gralinski, M R, Black, S C, Stancato, L F, Kilgore, K S, Campau, P A, Park, J L, Ozeck, M J, Pratt, W B, Lucchesi, B R

    Published in The American journal of physiology (01-08-1996)
    “…We determined if heat stress induction of heat shock protein (HSP) 70 modulates complement activation in an experimental model of xenograft rejection. Male New…”
    Get full text
    Journal Article
  12. 12

    Selective inhibition of the alternative complement pathway by sCR1[desLHR-a]protects the rabbit isolated heart from human complement-mediated damage by Gralinski, Michael R., Wiater, Bridget C., Assenmacher, Amy N., Lucchesi, Benedict R.

    Published in Immunopharmacology (01-09-1996)
    “…Evidence is presented that treatment with a selective inhibitor of the alternative complement pathway, sCR1[desLHR-A], protects the ex vivo perfused rabbit…”
    Get full text
    Journal Article
  13. 13

    LU 51198, a highly sulfated, low-molecular-weight heparin derivative, prevents complement-mediated myocardial injury in the perfused rabbit heart by Gralinski, M R, Park, J L, Ozeck, M A, Wiater, B C, Lucchesi, B R

    “…Evidence is presented that treatment with a highly sulfated low-molecular-weight heparin fraction, LU 51198, protects the ex vivo perfused rabbit heart from…”
    Get more information
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    The dog's role in the preclinical assessment of QT interval prolongation by GRALINSKI, Michael R

    Published in Toxicologic pathology (2003)
    “…During the development of a new therapeutic, few pharmacodyamic outcomes currently receive as much scrutiny as the effect of a potential medication on the…”
    Get full text
    Conference Proceeding Journal Article
  18. 18

    Effects of supervisor style and empathy upon counselor learning by Payne, Paul A, Gralinski, Dennis M

    Published in Journal of counseling psychology (01-11-1968)
    “…Examined effects of supervisor style (techniques and counseling types) and supervisor empathy upon counselor learning of empathy in a supervision analogue. 3…”
    Get full text
    Journal Article
  19. 19
  20. 20